BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 17704247)

  • 21. Use of lipoplex-induced nuclear factor-kappaB activation to enhance transgene expression by lipoplex in mouse lung.
    Kuramoto T; Nishikawa M; Thanaketpaisarn O; Okabe T; Yamashita F; Hashida M
    J Gene Med; 2006 Jan; 8(1):53-62. PubMed ID: 16041832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma through baculovirus: a comparative study with Bac-CMV-hNIS.
    Guo R; Zhang R; Pan Y; Xu H; Zhang M; Liang S; Wang L; Zhang Y; Li B
    Nucl Med Commun; 2011 May; 32(5):402-9. PubMed ID: 21386735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
    Hsieh YJ; Ke CC; Liu RS; Wang FH; Tang KT; Chi CW; Chen FD; Lee CH
    Anticancer Res; 2007; 27(4B):2515-22. PubMed ID: 17695547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
    Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
    J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.
    Mairs RJ; Ross SC; McCluskey AG; Boyd M
    J Nucl Med; 2007 Sep; 48(9):1519-26. PubMed ID: 17704246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of CMV promoter-driven exogenous gene expression with doxorubicin in genetically modified cells.
    Kinoshita A; Kobayashi D; Hibino Y; Isago T; Uchino K; Yagi K; Hirai M; Saitoh Y; Komada F
    J Pharm Pharmacol; 2008 Dec; 60(12):1659-65. PubMed ID: 19000371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
    Lee YJ; Chung JK; Shin JH; Kang JH; Jeong JM; Lee DS; Lee MC
    Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of different nuclear factor kappaB dimers on the survival of immortalized neural progenitor cells].
    Gui LL; Zhang CH; Liu ZH; Chen ZJ; Zhu C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):871-5. PubMed ID: 18756949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
    Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
    Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo sodium iodide symporter gene therapy of prostate cancer.
    Spitzweg C; Dietz AB; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Gene Ther; 2001 Oct; 8(20):1524-31. PubMed ID: 11704812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats.
    Faivre J; Clerc J; Gérolami R; Hervé J; Longuet M; Liu B; Roux J; Moal F; Perricaudet M; Bréchot C
    Cancer Res; 2004 Nov; 64(21):8045-51. PubMed ID: 15520214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.
    Svensson RU; Barnes JM; Rokhlin OW; Cohen MB; Henry MD
    Cancer Res; 2007 Nov; 67(21):10445-54. PubMed ID: 17974988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
    Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.
    Shi Y; Zou M; Baitei EY; Alzahrani AS; Parhar RS; Al-Makhalafi Z; Al-Mohanna FA
    Cancer Gene Ther; 2008 Feb; 15(2):101-7. PubMed ID: 18197164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
    Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
    Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
    Jung KH; Paik JY; Ko BH; Lee KH
    J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.